Checking kidney function with blood thinners to reduce bleeding
Part of Blood & lymphatic clinical trials.
This study checks whether giving community pharmacists information about your kidney function when they fill your blood-thinner prescription can help reduce bleeding problems. If you take a direct oral anticoagulant (like apixaban or rivaroxaban), your participation could help improve how these medicines are managed safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a prescription for a direct oral anticoagulant (a pill that prevents blood clots), either for the first time or as a refill.
- You should not be taking any other type of anticoagulant (blood thinner).
- You cannot be pregnant or breastfeeding.
- You must be able to understand French and agree to participate by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
This study looks at whether older adults with atrial fibrillation are taking the right dose of their blood thinner medicine. It aims to improve how doctors prescribe these medications in primary care.
This study looks at how people doing well on certain blood thinners do when they have a stroke or bleeding while taking them. It will measure medication levels in your blood to understand stroke severity and recovery in the short and long term.
This study compares two strategies for managing atrial fibrillation (irregular heartbeat) in people on dialysis: one uses a blood thinner called apixaban to prevent strokes, and the other does not. The goal is to find out which approach is safer and more effective for this specific group.
This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.
This trial compares the bleeding risk of two commonly used blood thinners—rivaroxaban and apixaban—in people with atrial fibrillation (AF). If you’re starting an anticoagulant for a new AF diagnosis, this may help doctors choose the safer option for you and others.
Hear when a new AOD Prescription trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.